United States Oncology Based In-Vivo CRO Market with high CAGR during 2024-2031 - Exclusive Report by DatamIntelligence

"The Global Oncology Based In-Vivo CRO Market is expected to grow at a high CAGR during the forecast period (2024-2031)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/oncology-based-in-vivo-cro-market?sp

United States: Recent Industry Developments

✅ In September 2025, Charles River Laboratories expanded its oncology in-vivo CRO services with advanced mouse and rat tumor models, supporting preclinical efficacy testing for immuno-oncology and targeted therapies. The initiative accelerates drug development timelines.

✅ In August 2025, WuXi AppTec launched next-generation in-vivo oncology platforms integrating AI-based tumor growth analysis and imaging for improved study accuracy and predictive value.

✅ In July 2025, Crown Bioscience introduced comprehensive in-vivo models for hematologic and solid tumor research, enhancing translational research and therapeutic evaluation.

✅ In June 2025, Envigo invested in R&D for genetically engineered tumor models and automated monitoring systems to improve data reproducibility and preclinical oncology insights.

Japan: Recent Industry Developments

✅ In September 2025, Japan SLC expanded its in-vivo oncology CRO services with enhanced xenograft and PDX models, supporting efficient evaluation of new anti-cancer compounds.

✅ In August 2025, Oriental Yeast Co. launched automated imaging and tumor measurement platforms for in-vivo oncology studies, improving accuracy and workflow efficiency.

✅ In July 2025, Kissei Pharmaceutical enhanced preclinical oncology services with advanced mouse and rat tumor models, facilitating faster translation from bench to clinic.

✅ In June 2025, Shin Nippon Biomedical Laboratories invested in next-generation in-vivo oncology research platforms, combining imaging, AI analytics, and optimized study designs to support drug development.

Oncology Based In-Vivo CRO Market: Drivers

The oncology-based in-vivo contract research organization (CRO) market is witnessing robust growth, driven by increasing demand for preclinical cancer research, rising prevalence of various cancers, and the need for efficient drug development pipelines. In-vivo CRO services provide critical support in evaluating pharmacokinetics, pharmacodynamics, efficacy, and toxicity of oncology therapeutics using animal models, enabling faster and more accurate preclinical assessments. Advances in genetically engineered models, patient-derived xenografts (PDX), and humanized mice are enhancing the predictive value and translational relevance of preclinical studies. Growing outsourcing trends in pharmaceutical and biotech companies to reduce costs, accelerate timelines, and access specialized expertise are further supporting market adoption. Expansion of oncology research programs, clinical trials, and investments in novel cancer therapies is fueling demand for high-quality in-vivo CRO services.

Leading CRO providers, including Charles River Laboratories, Envigo, Covance, and Crown Bioscience, are offering specialized oncology-focused in-vivo services, covering solid tumors, hematological malignancies, and immuno-oncology studies. Strategic collaborations between CROs, biotech firms, and academic institutions are accelerating drug discovery, preclinical validation, and regulatory submissions. Integration of advanced imaging, biomarker analysis, and high-throughput screening technologies is enhancing the efficiency and accuracy of oncology in-vivo studies. Growing focus on personalized medicine, immunotherapy, and targeted cancer treatments is driving adoption of specialized preclinical models. With continuous innovation, rising cancer incidence, and increasing outsourcing by pharma and biotech companies, the oncology-based in-vivo CRO market is poised for sustained global growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/oncology-based-in-vivo-cro-market?sp

Oncology Based In-Vivo CRO Market: Major Players

Crown Bioscience, Charles River Laboratory, ICON Plc. Eurofins Scientific, Taconic Biosciences, Covance, Boji Pharmaceutical, Hunan Kailarui Biotech Co., Ltd., Xi'an Julong Bio-Tech Co., Ltd. among others.

Segment Covered in the Oncology Based In-Vivo CRO Market:

➥ By Indication: Blood Cancer, Solid Tumors, Others

➥ By Model: Syngeneic, Xenograft, Patient-Derived Xenograft (PDX), Others

➥ By End User: Research Organizations, Pharmaceutical Companies, Others

Research Process:

Both primary and secondary data sources have been used in the Oncology Based In-Vivo CRO Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Oncology Based In-Vivo CRO Market Research Industry:

➠ Who leads the Oncology Based In-Vivo CRO industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Oncology Based In-Vivo CRO market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Oncology Based In-Vivo CRO market growth?
➠ What are the dominant sales and distribution strategies in the Oncology Based In-Vivo CRO industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=oncology-based-in-vivo-cro-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.